Gilead Sciences signed a contract with four Indian pharmaceutical companies to produce its medication ‘Remdesivir’ which has been found effective in treatment of some COVID-19 patients.
Technical analyst Sudarshan Sukhani has suggested three BUY calls and one SELL call for today’s trading session. Indian markets are expected to open strong for today’s trading session.
Bulgaria and Croatia have been accepted in for two year waiting room before these European Union member states will be allowed to join Euro as currency.